Home World Negotiate to buy “molnupiravir” to help poor countries 300 baht / course

Negotiate to buy “molnupiravir” to help poor countries 300 baht / course

by news dir

The World Health Organization said it was negotiating with Merck to buy molnupiravir for only 300 baht/course to help poor countries.

Reuters reported today, citing a draft document that said: The World Health Organization (WHO) has a program to help poor countries access vaccines and anti-COVID-19 drugs.

Although the WHO did not directly specify the procurement of molnupiravir, But the document states that the Access to COVID-19 Tools Accelerator (ACT-A) program plans to purchase. “New oral drug for the treatment of COVID-19 patients with mild to moderate symptoms” and other drugs being developed for the treatment of COVID-19, 28 million courses for $10 each

The ACT-A program also plans to purchase another 4.3 million courses of medication to treat COVID-19 patients. with severe symptoms The drug is purchased for $28 per course. Molnupiravir is now understood to be the only drug with outstanding efficacy in a phase 3 trial for treating patients. Covid-19

The ACT-A program is in talks with Merck & Co., the manufacturer of molnupiravir. It also negotiated with other generic drugmakers to buy molnupiravir at a cost of $10 per course, which, if the negotiations were successful, would allow the WHO to buy molnupiravir in the US. cheap price Compared to the US government’s purchase of molnupiravir from Merck for $700 per course, the US government has ordered 1.7 molnupiravir. million courses with a limit of $1,2 billion

One course contains 40 tablets of 200 mg molnupiravir for one patient, four tablets twice daily for five days.

The Harvard School of Public Health and King’s College Hospital previously released reports that Merck’s cost of producing molnupiravir is just $17.74 per course, and would cost it as low as $7.7 per course if the drug was made at its maximum efficiency. But Merck has charged the U.S. government the price of the drug as high as $700 per course, 40 times the cost.

See also  Nicaragua presidential election, Ortega International Criticism|Morning & World

Meanwhile, the ACT-A program aims to deliver 1 billion COVID-19 test kits to poor countries. and providing anti-Covid-19 drugs to treat 120 million patients worldwide. Meanwhile, 200 million new cases are projected over the next 12 months.

The document states that the ACT-A program plans to reach an agreement by the end of November to “Providing oral medicines to treat COVID-19 for outpatients,” with the goal of delivering the drug to countries in the first quarter of 2022.

However, a spokesman for the ACT-A program said the document, dated Oct. 13, was still a draft. and is under discussion A spokesperson declined to comment on the content of the document. before reaching a conclusion

The ACT-A program will deliver this document to global leaders ahead of the G20 Rome summit later this month. and will call on the G20 to raise an additional $22.8 billion in aid through September 2022. for the provision of vaccines and anti-COVID-19 drugs to poor countries After donor nations previously pledged $185 billion in aid to the ACT-A program.

Information from: Reuters.

Picture from : AFP

Related Articles

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.